Kenya to reduce import dependency with production of new site; Co-laboratory space to open in China
Square Pharmaceuticals will start production of its $74.36 million factory in Kenya in early 2022, according to The Daily Nation.
The site from the Bangladeshi pharmaceutical leader will produce malaria and diabetes drugs, among other essential medicines. It will manufacture more than 2 billion tablets and capsules a year, enough to make it the largest pharmaceutical manufacturing plant in East and Central Africa. The Kenyan workforce will get technology and training to make the drugs, the company said in a statement Monday.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
